Xponance’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.2M | Buy |
93,993
+3,771
| +4% | +$329K | 0.07% | 231 |
|
|
2025
Q1 | $6.16M | Buy |
90,222
+1,023
| +1% | +$69.9K | 0.06% | 256 |
|
|
2024
Q4 | $6.94M | Sell |
89,199
-948
| -1% | -$73.7K | 0.06% | 235 |
|
|
2024
Q3 | $6.04M | Buy |
90,147
+687
| +0.8% | +$46.1K | 0.06% | 255 |
|
|
2024
Q2 | $10.1M | Buy |
89,460
+2,141
| +2% | +$243K | 0.1% | 148 |
|
|
2024
Q1 | $12.1M | Buy |
87,319
+1,594
| +2% | +$221K | 0.13% | 138 |
|
|
2023
Q4 | $10.6M | Sell |
85,725
-2,878
| -3% | -$357K | 0.13% | 133 |
|
|
2023
Q3 | $8.27M | Buy |
88,603
+1,701
| +2% | +$159K | 0.11% | 155 |
|
|
2023
Q2 | $11.2M | Buy |
86,902
+1,842
| +2% | +$237K | 0.15% | 114 |
|
|
2023
Q1 | $9.88M | Buy |
85,060
+1,245
| +1% | +$145K | 0.14% | 127 |
|
|
2022
Q4 | $9.49M | Buy |
83,815
+5,389
| +7% | +$610K | 0.15% | 127 |
|
|
2022
Q3 | $6.32M | Sell |
78,426
-429
| -0.5% | -$34.5K | 0.12% | 150 |
|
|
2022
Q2 | $5.88M | Sell |
78,855
-2,005
| -2% | -$149K | 0.12% | 153 |
|
|
2022
Q1 | $10.3M | Buy |
80,860
+856
| +1% | +$109K | 0.17% | 96 |
|
|
2021
Q4 | $10.7M | Buy |
80,004
+20,968
| +36% | +$2.81M | 0.17% | 99 |
|
|
2021
Q3 | $8.07M | Sell |
59,036
-1,668
| -3% | -$228K | 0.15% | 120 |
|
|
2021
Q2 | $6.48M | Buy |
60,704
+5,916
| +11% | +$632K | 0.12% | 149 |
|
|
2021
Q1 | $4.92M | Sell |
54,788
-32
| -0.1% | -$2.88K | 0.1% | 171 |
|
|
2020
Q4 | $5.07M | Buy |
54,820
+1,016
| +2% | +$93.9K | 0.11% | 161 |
|
|
2020
Q3 | $5.55M | Buy |
53,804
+708
| +1% | +$73K | 0.14% | 134 |
|
|
2020
Q2 | $5.38M | Buy |
+53,096
| New | +$5.38M | 0.14% | 149 |
|